Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation... Read more
25 people · 0 jobs
8 people · 0 jobs
9 people · 0 jobs
6 people · 0 jobs
10 people · 0 jobs
7 people · 0 jobs